← Back to all trials
Active Not Recruiting
NCT05630599
Remote Assessment of Lung Disease and Impact on Physical and Mental Health
Conditions: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Covid19
Sex: All
Ages: 18 Years – 100 Years
Enrollment: 60
Sponsor: University College, London
Location: United Kingdom
Summary
This cohort study aims to use the open-source RADAR-base mHealth platform to collect and analyze datasets associated with lung disease.
This will include continuous data collected from wearable devices (e.g.
heart rate, oxygen saturation, respiratory rate), including pulse oximeters, spirometer, mobile phones, digital tests, and smart phone symptom questionnaires.
Eligibility Criteria
Inclusion Criteria:20 patients with a diagnosis of COPD20 patients with a diagnosis of interstitial lung disease20 a clinical diagnosis of COVID-19 (within 4-13 weeks of enrolment) who either and report symptoms interfering with day to day activity present for more than 28 days following the onset of COVID-19Prior mobile phone useWillingness to use monitoring devices and complete study questionnaires.History of exacerbation (COPD: 2 or more exacerbations in last 1 yr)Exclusion Criteria:Non English language SpeakerLack of physical capability to take part e.g.
Heart FailurePregnancyLack of capability to consent
Source: ClinicalTrials.gov (NCT05630599). StuddyBuddy aggregates publicly available trial information.
